scholarly journals Structural and Functional Characterization of Nonstructural Protein 2 for Its Role in Hepatitis C Virus Assembly

2008 ◽  
Vol 283 (42) ◽  
pp. 28546-28562 ◽  
Author(s):  
Vlastimil Jirasko ◽  
Roland Montserret ◽  
Nicole Appel ◽  
Anne Janvier ◽  
Leah Eustachi ◽  
...  
2010 ◽  
Vol 6 (12) ◽  
pp. e1001233 ◽  
Author(s):  
Vlastimil Jirasko ◽  
Roland Montserret ◽  
Ji Young Lee ◽  
Jérôme Gouttenoire ◽  
Darius Moradpour ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Katarzyna Grzyb ◽  
Anna Czarnota ◽  
Agnieszka Brzozowska ◽  
Anna Cieślik ◽  
Łukasz Rąbalski ◽  
...  

Hepatology ◽  
2009 ◽  
Vol 50 (5) ◽  
pp. 1638-1645 ◽  
Author(s):  
Sandra Ciesek ◽  
Eike Steinmann ◽  
Heiner Wedemeyer ◽  
Michael P. Manns ◽  
Johann Neyts ◽  
...  

2000 ◽  
Vol 74 (2) ◽  
pp. 702-709 ◽  
Author(s):  
Mike Flint ◽  
Jean Dubuisson ◽  
Catherine Maidens ◽  
Richard Harrop ◽  
Geoffrey R. Guile ◽  
...  

ABSTRACT The E2 protein of hepatitis C virus (HCV) is believed to be a virion surface glycoprotein that is a candidate for inclusion in an antiviral vaccine. A truncated soluble version of E2 has recently been shown to interact with CD81, suggesting that this protein may be a component of the receptor for HCV. When expressed in eukaryotic cells, a significant proportion of E2 forms misfolded aggregates. To analyze the specificity of interaction between E2 and CD81, the aggregated and monomeric forms of a truncated E2 glycoprotein (E2661) were separated by high-pressure liquid chromatography and analyzed for CD81 binding. Nonaggregated forms of E2 preferentially bound CD81 and a number of conformation-dependent monoclonal antibodies (MAbs). Furthermore, intracellular forms of E2661 were found to bind CD81 with greater affinity than the extracellular forms. Intracellular and secreted forms of E2661 were also found to differ in reactivity with MAbs and human sera, consistent with differences in antigenicity. Together, these data indicate that proper folding of E2 is important for its interaction with CD81 and that modifications of glycans can modulate this interaction. Identification of the biologically active forms of E2 will assist in the future design of vaccines to protect against HCV infection.


Gene ◽  
1996 ◽  
Vol 182 (1-2) ◽  
pp. 203-211 ◽  
Author(s):  
Yoshihiro Ide ◽  
Luwen Zhang ◽  
Min Chen ◽  
Genevieve Inchauspe ◽  
Chander Bahl ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document